Teva Again Tells High Court To Nix Claim Construction Rule
Teva Pharmaceuticals USA Inc. has urged the U.S. Supreme Court to ignore Sandoz Inc. and Mylan Inc.'s argument to uphold a ruling that found several patents for Teva's multiple sclerosis drug...To view the full article, register now.
Already a subscriber? Click here to view full article